Dr. Tom Frieden, Director of the Centers for Disease Control and Prevention, keynote presentation at the National Rx Drug Abuse & Heroin Summit on March 30, 2016.
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
Dr. Tom Frieden keynote
1. Centers for Disease Control and Prevention
From Sounding the Alarm to Turning the Tide:
Action to Combat the Opioid Epidemic
Tom Frieden, MD, MPH
Director, Centers for Disease Control and Prevention
National Rx Drug Abuse & Heroin Summit
March 30, 2016
3. 1999 DRUG OVERDOSE DEATH RATES
Designed by L. Rossen, B. Bastian & Y. Chong. SOURCE: CDC/NCHS, National Vital Statistics System
4. 2002 RAPID INCREASE IN DRUG OVERDOSE DEATH RATES
Designed by L. Rossen, B. Bastian & Y. Chong. SOURCE: CDC/NCHS, National Vital Statistics System
5. 2005 RAPID INCREASE IN DRUG OVERDOSE DEATH RATES
Designed by L. Rossen, B. Bastian & Y. Chong. SOURCE: CDC/NCHS, National Vital Statistics System
6. 2008 RAPID INCREASE IN DRUG OVERDOSE DEATH RATES
Designed by L. Rossen, B. Bastian & Y. Chong. SOURCE: CDC/NCHS, National Vital Statistics System
7. 2011 RAPID INCREASE IN DRUG OVERDOSE DEATH RATES
Designed by L. Rossen, B. Bastian & Y. Chong. SOURCE: CDC/NCHS, National Vital Statistics System
8. 2014 RAPID INCREASE IN DRUG OVERDOSE DEATH RATES
Designed by L. Rossen, B. Bastian & Y. Chong. SOURCE: CDC/NCHS, National Vital Statistics System
9. The amount of opioids
prescribed has
But the pain that Americans
report remains
10. Any one of these could potentially ruin – or end – a patient’s life
Prescriptions for opioids
were written by health
care providers in 2013
11. OPIOID PRESCRIBING RATES ARE 3X HIGHER IN SOME
STATES THAN OTHERS
Source: MMWR Vital Signs, July 2014. Source: IMS, National Prescription Audit (NPATM), 2012.
12. SHARP INCREASES IN HEROIN AND OPIOID DEATH RATES
IN RECENT YEARS
0.0
1.0
2.0
3.0
4.0
5.0
6.0
7.0
8.0
9.0
10.0
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Deathsper100,00population
prescription opioid
(natural or semi-synthetic
opioid or methadone)
illicit opioid (heroin)
unknown whether
prescription or illicit opioid
(synthetic opioid)
any opioid (prescription or
illicit)
Source: CDC/NCHS, National Vital Statistics System, Mortality.
13. THE OPIOID EPIDEMIC INVOLVES INTERSECTION AND
OVERLAP OF BOTH PRESCRIPTION AND ILLICIT OPIATES
3 out of 4 people
reporting Rx opioid and
heroin use in past year
took Rx opioids first
7 out of 10 people who
used heroin in the past year
also misused opioids in the
past year
14. SCOTT COUNTY, INDIANA: SENTINEL EVENT
Epicenter of 2015 injection drug-associated
HIV outbreak (Opana)
80% co-infected with HCV
15. VULNERABILITY TO HIV/HCV INFECTIONS AMONG
PERSONS WHO INJECT DRUGS
26 states with 1 or more
vulnerable counties
Ranked index
Top 220 counties
16. TWO GROUPS, TWO DIFFERENT SETS OF NEEDS
Addicted/Dependent
Need access
to services
At risk for addiction/dependence
Protect from
dangerous drugs
17. POSSIBLE TECHNICAL PACKAGE TO STOP THE OPIOID
OVERDOSE EPIDEMIC
Rigorous, real-time monitoring with adaptive response
Improve prescribing for pain Improve management of addiction
Prescription drug monitoring programs, science-
based guidelines, pain clinic laws, prescribing
defaults in EHRs, prior authorization for risky
prescriptions, patient review and restriction
programs, naloxone prescriptions, etc.
Involve payors including Medicaid/Medicare, health
systems, pharmacy benefit plans; clinicians; patients
Increase access to medication-assisted treatment
and improve quality and accountability for treatment
outcomes
Link people to treatment and support them through
recovery and living with addiction
Increase access to naloxone for emergency reversals
Partner with law enforcement Community awareness and support
Enforce laws, policies and regulations to reduce
diversion, abuse & overdose
Reduce availability of illicit drugs
Criminal justice system as entry point for addiction
treatment
Increase awareness of risks and benefits of opioids
Promote economic development to reduce
initiation/continuation of drug use
18. POSSIBLE TECHNICAL PACKAGE TO STOP THE OPIOID
OVERDOSE EPIDEMIC
Rigorous, real-time monitoring with adaptive response
Reduce
Supply
Improve management of addiction
Increase access to medication-assisted treatment
and improve quality and accountability for treatment
outcomes
Link people to treatment and support them through
recovery and living with addiction
Increase access to naloxone for emergency reversals
Community awareness and support
Increase awareness of risks and benefits of opioids
Promote economic development to reduce
initiation/continuation of drug use
19. POSSIBLE TECHNICAL PACKAGE TO STOP THE OPIOID
OVERDOSE EPIDEMIC
Rigorous, real-time monitoring with adaptive response
Improve prescribing for pain
Reduce
Demand
Prescription drug monitoring programs, science-
based guidelines, pain clinic laws, prescribing
defaults in EHRs, prior authorization for risky
prescriptions, patient review and restriction
programs, naloxone prescriptions, etc.
Involve payors including Medicaid/Medicare, health
systems, pharmacy benefit plans; clinicians; patients
Partner with law enforcement
Enforce laws, policies and regulations to reduce
diversion, abuse & overdose
Reduce availability of illicit drugs
Criminal justice system as entry point for addiction
treatment
20. REDUCE SUPPLY: IMPROVE PRESCRIBING FOR PAIN
1. Non-opioid therapy preferred for chronic pain outside of active cancer,
palliative, and end-of-life care
2. When opioids are used, start low and go slow
3. Clinicians should always exercise caution when prescribing opioids and
monitor all patients closely
23. We know of no other medication
routinely used for a nonfatal
condition that kills patients so
frequently
DEATH
24. Initiation of treatment with
opioids is a momentous decision
and should be undertaken only
with full understanding by both
the physician and the patient of
the substantial risks involved
MOMENTOUS DECISION
Frieden TR, Houry D. Reducing the Risks of Relief – The CDC Opioid-Prescribing Guideline. N Engl J Med. 2016 Mar 15. [Epub ahead of print].
26. ADDICTION MANAGEMENT AND TREATMENT
Most people with addiction are not receiving
medication-assisted treatment
No more than 1
million
At Least 1.5
million
Receiving MAT
Not Receiving MAT
Volkow et al. NEJM 2014;370:2063-2066.
27. COMMUNITY AWARENESS AND SUPPORT
Engaged and empowered
communities support patients
and families
We can work together to both
prevent addiction and support
recovery
The structure of our communities
structures our lives in many more
ways than we recognize
28. WE ALL HAVE A ROLE TO PLAY
Patients
Ask your doctor if an opioid is
needed, and if so for how long
and what’s the goal
Doctors
Consider other treatments first;
start low & go slow; follow up
Health systems
Use guideline to implement
own guidance
Insurers
Structure evidence-based programs and
evaluate strategies to improve patient
safety
State governments
Improve prescribing; maximize PDMPs
Federal government
Continue to refine based on data; expand
access to care including methadone,
buprenorphine, naltrexone, naloxone
29.
30. Public health, law enforcement, industry & communities
working together cut crash deaths in half
WE CAN DO THE SAME FOR OVERDOSES
0
5
10
15
20
25
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
Deathsper100,000population
Motor Vehicle Crash Overdose
Data: NCHS.
31. POSSIBLE TECHNICAL PACKAGE TO STOP THE OPIOID
OVERDOSE EPIDEMIC
Use data to improve performance
Improve prescribing for pain Improve management of addiction
Partner with law enforcement Community awareness and support
32. DRUG POISONING DEATH RATES HAVE INCREASED IN
ALMOST EVERY STATE
0
5
10
15
20
25
30
35
40 WestVirginia
NewMexico
NewHampshire
Kentucky
Ohio
RhodeIsland
Utah
Pennsylvania
Delaware
Oklahoma
Tennessee
Wyoming
Massachusetts
Nevada
Missouri
Indiana
Arizona
Michigan
Connecticut
Maryland
Louisiana
Maine
Alaska
Colorado
Alabama
Wisconsin
UnitedStates
SouthCarolina
DistrictofColumbia
NewJersey
Vermont
NorthCarolina
Idaho
Washington
Florida
Illinois
Oregon
Arkansas
Montana
Georgia
Kansas
Virginia
Mississippi
NewYork
California
Hawaii
Texas
Minnesota
Iowa
SouthDakota
Nebraska
NorthDakota
Deathrate
(per100,000pop.,ageadjusted)
2010
2014
33.
34. For more information, contact CDC
1-800-CDC-INFO (232-4636)
TTY: 1-888-232-6348 www.cdc.gov
Editor's Notes
About as many American deaths as WWII, Korean & Vietnam Wars combined (518k total)
All-cause death rate decreased 5% (8.7 to 8.2 per 1,000)
# of deaths 2000: 2.4M
# of deaths 2013: 2.6M (latest)
Cumulative deaths 2000-2013: 35M (34.98M)
1.4% of deaths from drug overdose
OPIOID MISUSE AND ADDICTION CAN INVOLVE MANY DIFFERENT DRUGS
Naturally occurring opioid analgesics – including morphine and codeine
Semi-synthetic opioid analgesics – including pharmaceutical drugs such as oxycodone, hydrocodone, hydromorphone, and oxymorphone
Synthetic opioids
Methadone – pharmaceutical drug used to treat pain, or used as an opioid agonist maintenance therapy or to help with opioid detoxification
Fentanyl and Tramadol – legally made pharmaceutical drugs to treat pain; Fentanyl is also being manufactured illegally outside the US as a non-prescription drug
Heroin – an illegally made (illicit) semi-synthetic opioid derived from morphine
CDC OPIOID PRESCRIBING GUIDELINES FOR CHRONIC PAIN
Intended for primary care providers
Intended for patients 18 years old and up in chronic pain
Not intended for patients undergoing active cancer treatment, palliative care, or end-of-life care
Management of chronic pain is an art and a science.
The science of opioids for chronic pain is clear: for the vast majority of patients, the known, serious, and too-often-fatal risks far outweigh the unproven and transient benefits (and there are effective, safer alternatives).
More on what the Federal government can do (above probably summarizes this reasonably well)
- Support the use of prescription drug monitoring programs as a routine part of clinical practice.
- Increase Medicare / Medicaid coverage for nonpharmaceutical therapies
- Increase access to mental health and substance abuse treatment services through the Affordable Care Act.
- Expand use of Medication-Assisted Treatment (MAT).
- Support the development and distribution of the life-saving drug naloxone to reduce prescription opioid and heroin overdose deaths.
- Support the research, development, and approval of pain medications that are less prone to abuse.
- Improve surveillance to better track trends, identify communities at risk, and target prevention strategies.
- Support states that want to develop programs and policies to prevent prescription opioid overdose, while ensuring patients' access to safe, effective pain treatment.
- Improve patient safety by supplying health care providers with data, tools, and guidance for decision making based on proven practices.
PRESCRIPTION DRUG OVERDOSE PREVENTION FOR STATES
FY16 funding offered to all states
High impact, data driven activities and gives states flexibility to tailor their work
Real-time tracking and real-time response
Coordination with law enforcement
$10M increase requested in FY17 President’s Budget
Expansion to national PDO prevention program
For unfunded states, a new FOA (Prescription Drug Overdose: Data-Driven Prevention Initiative) will be issued to help states develop capacity needed to engage in work laid out in Prevention for States program
Competitive supplemental FOA will be released for currently funded states
Funding for opioid surveillance activities
States will be eligible to apply for funding to:
1) Increase timeliness of nonfatal opioid overdose reporting
2) Increase timeliness of fatal opioid overdose and associated risk factor reporting
3) Disseminate surveillance findings to key stakeholders working to prevent opioid-involved overdoses
All 50 states & DC eligible to apply with focus on states with high or rapidly changing burden and readiness to implement prevention strategies
CDC will also support improvements in national surveillance
The FY 2017 President’s Budget requests an increase of $10M to:
Fully expand efforts to promote opioid prescribing guideline dissemination and uptake
Create clinical decision support tools derived from guidelines to provide real-time assistance with prescribing decisions in a multitude of health care settings
Support and identify best practices in communities and states to prevent overdose
Scale up successful approaches that improve prescribing for chronic pain and reduce opioid overdose and death